Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics
10.3760/cma.j.cn112148-20200218-00093
- VernacularTitle: 疫情流行期间心力衰竭与新型冠状病毒肺炎患者临床及影像学特征的比较
- Author:
Zhaowei ZHU
1
;
Jianjun TANG
1
;
Xiangping CHAI
2
;
Zhenfei FANG
1
;
Qiming LIU
1
;
Xinqun HU
1
;
Dangyan XU
1
;
Liang TANG
1
;
Shi TAI
1
;
Yuzhi WU
2
;
Shenghua ZHOU
1
Author Information
1. Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China
2. Emergency Depratment, Second Xiangya Hospital of Central South University, Changsha, 410011, China
- Publication Type:Journal Article
- Keywords:
COVID-19;
Heart failure;
Pulmonary computed tomography
- From:
Chinese Journal of Cardiology
2020;48(0):E007-E007
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To identify the characteristics including clinical features and pulmonary computed tomography (CT) features of heart failure and novel coronavirus pneumonia(COVID-19).
Methods:This study was a retrospective study. A total of 7 patients with Heart failure and 12 patients with COVID-19 in the Second Xiangya Hospital of Central South University between December 1, 2019 and February 15, 2020 were enrolled. The baseline clinical and imaging features of the two groups were statistically analyzed.
Results:There was no significant difference in age and sex between the two groups, but the incidence of epidemiological contact history, fever or respiratory symptoms in the COVID-19 group was significantly higher than that in the heart failure group (12/12 vs. 2/7, P=0.001; 12/12 vs. 4/7, P<0.001). While the proportion of cardiovascular diseases and impaired cardiac function was significantly less than that of the heart failure group(2/12 vs.7/7, P<0.001; 0/12 vs.7/7, P<0.001). For imaging features, both groups had ground-glass opacity and thickening of interlobular septum, but the ratio of central and gradient distribution was higher in patients with heart failure than that in patients with COVID-19 (4/7 vs. 1/12, P=0.04). In heart failure group, the ratio of the expansion of small pulmonary veins was also higher (3/7 vs. 0, P=0.013), and the lung lesions can be significantly improved after effective anti-heart failure treatment. Besides, there are more disease with rounded morphology in COVID-19 (9/12 vs. 2/7, P=0.048) .
Conclusions:More patients with COVID-19 have epidemiological history and fever or respiratory symptoms. There are significant differences in chest CT features, such as enlargement of pulmonary veins, lesions distribution and morphology between heart failure and COVID-19.
